FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980016917> ?p ?o ?g. }

• W1980016917 endingPage "1946" @default.
• W1980016917 startingPage "1937" @default.
• W1980016917 abstract "To prevent and treat experimental arthritis via nasal administration of an altered peptide ligand (APL) from the major arthritogenic epitope in adjuvant-induced arthritis (AIA) and to explore the mechanisms involved.Peptides were administered nasally before and after induction of arthritis. Splenocytes and lymph node cells draining both the site of inflammation and the site of tolerance induction were used for cell transfer and were studied for antigen-specific T cell characteristics. In addition, attempts were made to stop T cell tolerance in vitro, using anticytokine antibodies.Nasal administration of a modulatory APL of the heat-shock protein 60 (Hsp60) 180-188 T cell epitope, alanine 183, had a suppressive effect in AIA that far exceeded that of the wild-type epitope. In addition to its effectiveness in preventing AIA, alanine 183 may be effective in the treatment of ongoing AIA. The protective effect of alanine 183 can be passively transferred using activated splenocytes. Nasal administration of alanine 183 did not lead to detectable T cell proliferation or interleukin-2 (IL-2) production in mandibular lymph node cells, while transforming growth factor beta (TGF beta), IL-10, and IL-4 were readily produced. Likewise, after nasally induced tolerance, followed by induction of arthritis, inguinal lymph node cells produced IL-4, TGF beta, and IL-10. After neutralizing in vitro the individual cytokines with anticytokine antibodies, only blocking of IL-10 production led to reversal of tolerance, at the site of tolerance induction and the site of inflammation.Nasal administration of an APL of Hsp60 180-188 induces highly effective protection against AIA through generation of regulatory cells that produce IL-4, TGF beta, and IL-10, whereas the induced tolerance is driven mainly by production of IL-10." @default.
• W1980016917 created "2016-06-24" @default.
• W1980016917 creator A5002471422 @default.
• W1980016917 creator A5013284869 @default.
• W1980016917 creator A5029596727 @default.
• W1980016917 creator A5051696148 @default.
• W1980016917 creator A5054159214 @default.
• W1980016917 creator A5065993015 @default.
• W1980016917 creator A5078949048 @default.
• W1980016917 date "2002-07-01" @default.
• W1980016917 modified "2023-10-18" @default.
• W1980016917 title "Inhibition of adjuvant‐induced arthritis by interleukin‐10‐driven regulatory cells induced via nasal administration of a peptide analog of an arthritis‐related heat‐shock protein 60 T cell epitope" @default.
• W1980016917 cites W1500134182 @default.
• W1980016917 cites W1526621387 @default.
• W1980016917 cites W1527404918 @default.
• W1980016917 cites W1530997192 @default.
• W1980016917 cites W175676769 @default.
• W1980016917 cites W1939480513 @default.
• W1980016917 cites W1968274103 @default.
• W1980016917 cites W1976912963 @default.
• W1980016917 cites W1982116697 @default.
• W1980016917 cites W1988317772 @default.
• W1980016917 cites W2001107275 @default.
• W1980016917 cites W2005263205 @default.
• W1980016917 cites W2012845063 @default.
• W1980016917 cites W2031331787 @default.
• W1980016917 cites W2036260827 @default.
• W1980016917 cites W2049710430 @default.
• W1980016917 cites W2068469424 @default.
• W1980016917 cites W2073401264 @default.
• W1980016917 cites W2073626398 @default.
• W1980016917 cites W2084406139 @default.
• W1980016917 cites W2086613584 @default.
• W1980016917 cites W2087062822 @default.
• W1980016917 cites W2090372222 @default.
• W1980016917 cites W2096094429 @default.
• W1980016917 cites W2101526205 @default.
• W1980016917 cites W2102629093 @default.
• W1980016917 cites W2113353984 @default.
• W1980016917 cites W2128707261 @default.
• W1980016917 cites W2156639896 @default.
• W1980016917 cites W2158521553 @default.
• W1980016917 cites W2158994974 @default.
• W1980016917 cites W2160738923 @default.
• W1980016917 cites W2163037816 @default.
• W1980016917 cites W2163802114 @default.
• W1980016917 cites W2169965176 @default.
• W1980016917 cites W4313331942 @default.
• W1980016917 doi "https://doi.org/10.1002/art.10366" @default.
• W1980016917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12124879" @default.
• W1980016917 hasPublicationYear "2002" @default.
• W1980016917 type Work @default.
• W1980016917 sameAs 1980016917 @default.
• W1980016917 citedByCount "67" @default.
• W1980016917 countsByYear W19800169172012 @default.
• W1980016917 countsByYear W19800169172013 @default.
• W1980016917 countsByYear W19800169172014 @default.
• W1980016917 countsByYear W19800169172015 @default.
• W1980016917 countsByYear W19800169172016 @default.
• W1980016917 countsByYear W19800169172017 @default.
• W1980016917 countsByYear W19800169172018 @default.
• W1980016917 countsByYear W19800169172020 @default.
• W1980016917 countsByYear W19800169172021 @default.
• W1980016917 countsByYear W19800169172022 @default.
• W1980016917 crossrefType "journal-article" @default.
• W1980016917 hasAuthorship W1980016917A5002471422 @default.
• W1980016917 hasAuthorship W1980016917A5013284869 @default.
• W1980016917 hasAuthorship W1980016917A5029596727 @default.
• W1980016917 hasAuthorship W1980016917A5051696148 @default.
• W1980016917 hasAuthorship W1980016917A5054159214 @default.
• W1980016917 hasAuthorship W1980016917A5065993015 @default.
• W1980016917 hasAuthorship W1980016917A5078949048 @default.
• W1980016917 hasConcept C147483822 @default.
• W1980016917 hasConcept C195616568 @default.
• W1980016917 hasConcept C203014093 @default.
• W1980016917 hasConcept C2776090121 @default.
• W1980016917 hasConcept C2777077863 @default.
• W1980016917 hasConcept C2777702733 @default.
• W1980016917 hasConcept C2781013607 @default.
• W1980016917 hasConcept C71924100 @default.
• W1980016917 hasConcept C8891405 @default.
• W1980016917 hasConcept C98274493 @default.
• W1980016917 hasConceptScore W1980016917C147483822 @default.
• W1980016917 hasConceptScore W1980016917C195616568 @default.
• W1980016917 hasConceptScore W1980016917C203014093 @default.
• W1980016917 hasConceptScore W1980016917C2776090121 @default.
• W1980016917 hasConceptScore W1980016917C2777077863 @default.
• W1980016917 hasConceptScore W1980016917C2777702733 @default.
• W1980016917 hasConceptScore W1980016917C2781013607 @default.
• W1980016917 hasConceptScore W1980016917C71924100 @default.
• W1980016917 hasConceptScore W1980016917C8891405 @default.
• W1980016917 hasConceptScore W1980016917C98274493 @default.
• W1980016917 hasIssue "7" @default.
• W1980016917 hasLocation W19800169171 @default.
• W1980016917 hasLocation W19800169172 @default.
• W1980016917 hasOpenAccess W1980016917 @default.
• W1980016917 hasPrimaryLocation W19800169171 @default.
• W1980016917 hasRelatedWork W2059333433 @default.

• next